Verity Pharma

TRELSTAR

Manufacturer:

Verity Pharma

Trelstar HCPCS:

J3315

HCPCS Code Descriptor:

Injection, triptorelin pamoate, 3.75 mg

Category:

J Code

Trelstar NDCs:

74676-5906-01, 74676-5906-00, 74676-5904-00, 74676-5904-01, 74676-5902-01, 74676-5902-00

Primary Type:

Oncology

Generic/Specialty Status:

Single-Source

Route of Administration:

Intramuscular

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

74676-5906-01, 74676-5906-00, 74676-5904-00, 74676-5904-01, 74676-5902-01, 74676-5902-00

About Trelstar:

TRELSTAR is an Oncology drug manufactured by Verity Pharma and administered via the Intramuscular route of administration. The J Code: J3315 is aligned to the drug TRELSTAR.

ACCESS PRICING AND MORE BY REGISTERING

J3315 Added Date:

January 1, 2003

J3315 Effective Date:

January 1, 2003

J3315 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Trelstar billing and coding information.
Our team did not identify a source for Trelstar patient assistance information. Please reach out to our team if you feel that this is a mistake.
TRELSTAR prescribing information can be found at the link below:
Information regarding TRELSTAR’s side effects can be found at MedlinePlus